Amgen Inc at Evercore ISI Healthcare Conference Transcript

Dec 03, 2025 / 03:00PM GMT
Release Date Price: €243.85
Umer Raffat
Evercore Inc - Moderator

Super excited to have Amgen management with us. I'll let you guys kick things off and we'll jump right in.

Peter Griffith
Amgen Inc - Chief Financial Officer, Executive Vice President

Great. Umer, thank you so much for inviting us. Again, we're always pleased to be here with you and with Evercore. At Amgen, you know our mission, our mission is to discover, develop, manufacture and deliver innovative first-in-class and/or best-in-class medicines to patients with serious illnesses all over the world. So we're glad to be here today. We continue to invest in innovation and science that enables longer, healthier lives with a strong long-term growth outlook, driven by breadth and depth across our four therapeutic areas.

We're entering the final stretch of the year. I think we can say that since it's December 3, with great momentum across the business. We delivered 10% revenue growth through the first nine months ending in September, inclusive of 11% product sales growth, and that was driven by 14% volume growth. And

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot